Ca 19-9 serum levels in patients with end-stage Idiopathic Pulmonary Fibrosis (IPF)
E. Balestro (Padova, Italy), E. Cocconcelli (Padova, Italy), D. Biondini (Padova, Italy), F. Fracasso (Padova, Italy), G. Castelli (Padova, Italy), G. Marulli (Padova, Italy), F. Rea (Padova, Italy), M. Cosio (Padova, Italy), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy)
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Balestro (Padova, Italy), E. Cocconcelli (Padova, Italy), D. Biondini (Padova, Italy), F. Fracasso (Padova, Italy), G. Castelli (Padova, Italy), G. Marulli (Padova, Italy), F. Rea (Padova, Italy), M. Cosio (Padova, Italy), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy). Ca 19-9 serum levels in patients with end-stage Idiopathic Pulmonary Fibrosis (IPF). 2929
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: